Laden...
| The final national coverage determination (NCD) on Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection will not be posted by the expected completion date of October 10, 2023. A final decision will be forthcoming. CMS received several public comments that expressed concern over the potentially complex transition of coverage of these drugs from Part D to Part B. CMS will work with Part D plans and pharmacies to facilitate an orderly transition to minimize any disruption in access for those beneficiaries currently on PrEP as we work towards finalizing the NCD. |
| Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page. |
| If you have any questions about this update, please email[email protected]. You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS). Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS). |
|
Laden...
Laden...
